It is being reported by Harris Martin that the plaintiffs’ involved in the first three DePuy ASR Hip Implant settlement cases that were previously set for trial in Nevada are now disputing the news reports of the confidential settlement for only $600,000 and/or $200,000 per claim. Because of the confidential settlement terms required by DePuy Orthopedics and Johnson & Johnson in these three cases, the attorneys involved essentially cannot comment on or give the stated the terms of the DePuy ASR settlement unless the confidential terms in the agreement are voided out. In order to set the record straight, according to reports, and in an effort to void the confidential terms pertaining to the settlement amount specifically, the Plaintiffs are asking a Nevada judge for permission to counter what they say are inaccurate details of the settlement amount on each case recently leaked to a media outlet by the defendants or some related party/affiliation to the defendants. It would be very interesting to learn for certain, and an unprecedented action taken, if this turns out to be an intentional act by the DePuy ASR defendants (or someone tangentially related to them or the ASR litigation) to mislead victims about the perceived value of their filed claims. It is too early to form any real opinions just yet on the topic but this will certainly be a carefully watched development and Motion over the next few weeks.
Other Depuy ASR Hip Implant News
Broadspire manages limited reimbursement programs for recalled DePuy and Stryker hip implants—but these benefits are not guaranteed and may impact your legal rights. Consult an attorney before proceeding.
DePuy has announced a second round of ASR hip implant settlements for patients with revision surgeries through January 2015. Learn who qualifies and what this new proposal could mean for you.
DePuy has proposed a major settlement for U.S. patients who underwent revision surgery due to recalled ASR hip implants, potentially offering compensation through base and supplemental award funds.
A California jury awarded $8.38 million to a DePuy ASR hip implant victim, finding the device was defectively designed—marking a pivotal outcome in the first jury trial of its kind.
Federal prosecutors are investigating Johnson & Johnson’s marketing of recalled hip implants amid growing concerns over device failures and the company’s prior legal troubles.
Over 10,000 DePuy ASR hip implant lawsuits have been filed nationwide, with multiple Bellwether trials underway. Learn where cases stand and what this could mean for affected patients.
